MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617038226 A) filed by Shenzhen Targetrx Co. , Ltd. on March 27, 2026, for Heterocyclic Fused Ring Compound, And Composition And Use Thereof.
Inventors include Wang, Yihan; Zhao, Jiuyang; and Ai, Yixin.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present invention relates to a compound of formula (I), or a tautomer, stereoisomer, prodrug, crystal form, pharmaceutically acceptable salt, hydrate or solvate thereof, a pharmaceutical composition thereof, and a use thereof in the treatment and/or prevention of diseases modulated by wild-type and/or mutant Bcr-Abl1 kinase.
Disclaimer: Curated by HT Syndication.
